[Therapeutic strategies in acute decompensated heart failure and cardiogenic shock].

Der Internist
M BuerkeK Werdan

Abstract

As the population of elderly people is increasing, the number of patients requiring hospitalization for acute exacerbations is rising. Traditionally, these episodes of hemodynamic instability were viewed as a transient event characterized by systolic dysfunction, low cardiac output, and fluid overload. Diuretics, along with vasodilator and inotropic therapy, eventually became elements of standard care. In a multicenter observational registry (ADHERE--Acute Decompensated Heart Failure National Registry) of more than 275 hospitals, patients with acute decompensated heart failure were analyzed for their characteristics and treatments options. These data have shown that this population consists of multiple types of heart failure, various forms of acute decompensation, combinations of comorbidities, and varying degrees of disease severity. The challenges in the treatment require multidisciplinary approaches since patients typically are elderly and have complex combinations of comorbidities. So far only a limited number of drugs is currently available to treat the different groups. Over the past years it was shown that even "standard drugs" might be deleterious by induction of myocardial injury, worsening of renal function or increas...Continue Reading

References

May 13, 1999·The American Journal of Medicine·B K KrämerG A Riegger
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
Jan 5, 2000·American Heart Journal·H M KrumholzR I Horwitz
Sep 29, 2000·The American Journal of Cardiology·M KorenyP Siostrzonek
Jan 4, 2001·The New England Journal of Medicine·S K GandhiW C Little
Feb 15, 2001·JAMA : the Journal of the American Medical Association·J S HochmanUNKNOWN SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock
Feb 15, 2001·Current Cardiology Reports·G M Felker, C M O'Connor
May 18, 2001·Current Opinion in Cardiology·G CotterZ Vered
Aug 30, 2001·American Heart Journal·G M Felker, C M O'Connor
Mar 28, 2002·JAMA : the Journal of the American Medical Association·Michael S CuffeUNKNOWN Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigato
May 23, 2002·The American Journal of the Medical Sciences·Ariel G BentancurRachel S Dankner
Jun 12, 2003·The American Journal of Medicine·Gordon D SchiffRobert A McNutt
Jul 10, 2003·American Heart Journal·Craig R LeeKirkwood F Adams
Aug 13, 2003·Circulation·Edmond W ChenUNKNOWN Investigators in the National Registry of Myocardial Infarction 2
Sep 10, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Bernard S P ChinGregory Y H Lip
Oct 18, 2003·Journal of the American College of Cardiology·Timothy A SanbornUNKNOWN SHOCK Investigators
Oct 19, 2004·Journal of the American College of Cardiology·Justin EzekowitzUNKNOWN APPROACH Investigators
Oct 19, 2004·Journal of the American College of Cardiology·Kirsten Bibbins-DomingoMichael G Shlipak
Mar 23, 2005·Circulation·Jonathan D Sackner-BernsteinKeith D Aaronson
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
Sep 27, 2005·The American Journal of Cardiology·Mihai GheorghiadeChristopher M O'Connor
Oct 4, 2005·The American Journal of Cardiology·Mihai GheorghiadeGary S Francis
Dec 6, 2005·Journal of the American College of Cardiology·Maria Rosa CostanzoPaul Sobotka
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Judith S HochmanUNKNOWN SHOCK Investigators
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators

❮ Previous
Next ❯

Citations

Jun 13, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·U Janssens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Journal of Cardiovascular Pharmacology and Therapeutics
Rohit R Arora
Minerva urologica e nefrologica = The Italian journal of urology and nephrology
F M Van Der SandeK M L Leunissen
© 2021 Meta ULC. All rights reserved